Free Float -
Shares Float -
Shares Outstanding 1,12 M
GLOBAL X GENOMICS & BIOTECHNOLOGIESLOGY ETF ETF · US37954Y4347 · GNOM (XNAS) Global X · TER 0,50 % · USA · Financial Services — real-time prices and quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of GLOBAL X GENOMICS & BIOTECHNOLOGIESLOGY ETF
No Price
18.05.2026 20:00
Current Prices from GLOBAL X GENOMICS & BIOTECHNOLOGIESLOGY ETF
| Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
|---|---|---|---|---|---|
 NASDAQ |
GNOM
|
USD
|
18.05.2026 20:00
|
44,01 USD
| -0,31 USD
-0,69 %
|
 IEX |
GNOM
|
USD
|
18.05.2026 19:24
|
43,94 USD
| -0,37 USD
-0,85 %
|
Share Float & Liquidity
Asset Allocation
| Asset | Percentage % |
|---|---|
| Equity | 91,73 % |
| Other | 8,14 % |
Largest Positions(50)
Updated on 18.05.2026 16:26:24
| Symbol | ISIN | CUSIP | Name | Shares | Market Value | Percentage % |
|---|---|---|---|---|---|---|
| ILMN | US4523271090 | 452327109 | ILLUMINA INC | 16.512 | 2,35 M EUR | 4,71 % |
| LEGN | US52490G1022 | 52490G102 | LEGEND BIOTECH CORP-ADR | 83.099 | 2,29 M EUR | 4,58 % |
| GH | US40131M1099 | 40131M109 | GUARDANT HEALTH INC | 24.059 | 2,28 M EUR | 4,57 % |
| ARWR | US04280A1007 | 04280A100 | ARROWHEAD PHARMACEUTICALS IN | 29.150 | 2,23 M EUR | 4,47 % |
| PRAX | US74006W2070 | 74006W108 | PRAXIS PRECISION MEDICINES I | 6.388 | 2,19 M EUR | 4,38 % |
| VRTX | US92532F1003 | 92532F100 | VERTEX PHARMACEUTICALS INC | 4.923 | 2,15 M EUR | 4,31 % |
| BMRN | US09061G1013 | 09061G101 | BIOMARIN PHARMACEUTICAL INC | 39.792 | 2,06 M EUR | 4,13 % |
| NTRA | US6323071042 | 632307104 | NATERA INC | 10.370 | 1,93 M EUR | 3,87 % |
| MRNA | US60770K1079 | 60770K107 | MODERNA INC | 38.755 | 1,9 M EUR | 3,81 % |
| CRSP | CH0334081137 | H17182108 | CRISPR THERAPEUTICS AG | 38.191 | 1,85 M EUR | 3,70 % |
Country Distribution
| Country | Percentage % |
|---|---|
| USA | 79,91 % |
| Other | 5,53 % |
| Switzerland | 3,70 % |
| Germany | 3,56 % |
| China | 2,30 % |
| United Kingdom and Northern Ireland | 2,00 % |
| Netherlands | 1,69 % |
| Singapore | 1,18 % |
Sector Distribution
| Sector | Percentage % |
|---|---|
| Healthcare | 94,03 % |
| Other | 5,53 % |
| Technology | 0,31 % |
Industry Distribution
| Industry | Percentage % |
|---|---|
| Biotechnology | 53,43 % |
| Medical - Diagnostics & Research | 19,78 % |
| Medical - Pharmaceuticals | 7,67 % |
| Drug Manufacturers - General | 6,45 % |
| Other | 5,53 % |
| Medical - Healthcare Information Services | 3,88 % |
| Medical - Equipment & Services | 2,48 % |
| Medical - Devices | 0,34 % |
| Hardware, Equipment & Parts | 0,31 % |
Currency Distribution
| Currency | Percentage % |
|---|---|
| USD | 86,10 % |
| EUR | 11,77 % |
| GBP | 2,00 % |
Invested Funds
The following funds have invested in GLOBAL X GENOMICS & BIOTECHNOLOGIESLOGY ETF:
Fund | Vol. in million 10.930,01 | Percentage (%) 10,25 % |
Company Profile for GLOBAL X GENOMICS & BIOTECHNOLOGIESLOGY ETF ETF
The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, "Genomics & Biotechnology Companies"), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.
Fund Master Data
Issuer Global X
Asset Class ETF
Name Global X - Genomics & Biotechnology ETF
Asset Class Equity
Fund Currency USD
Total Expense Ratio (TER) 0,50 %
Domicile United States
Website globalxetfs.com
Fund Key Figures
Fund Size 251.044,51 EUR
NAV 44.41
AUM 49,95 M EUR
Avg. Daily Volume 79.357
Investment Strategy
The Global X Genomics & Biotechnology ETF (GNOM) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Genomics Index.
Updated on 18.05.2026 14:50:46
Company Data
Name GLOBAL X GENOMICS & BIOTECHNOLOGIESLOGY ETF
Company Global X Genomics & Biotechnology ETF
Symbol GNOM
Primary Exchange
NASDAQ
NASDAQ
ISIN US37954Y4347
Asset Class ETF
Sector Financial Services
Industry Asset Management - Global
Market Capitalization 51 Mio
Country USA
Currency USD
Employees -
IPO Date 2019-04-10
Dividends from 'GLOBAL X GENOMICS & BIOTECHNOLOGIESLOGY ETF'
| Ex-Date | Dividend per Share |
|---|---|
| 30.12.2025 | 0,59 USD |
| 27.06.2025 | 0,008 USD |
| 30.12.2021 | 0,007 USD |
| 30.12.2020 | 0,03 USD |
Stock Splits
| Date | Split |
|---|---|
| 02.09.2025 | 1:4 |
Ticker Symbols
| Name | Symbol |
|---|---|
| NASDAQ | GNOM |